Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone: effects and complications.
[coats disease]
AIM
To
evaluate
the
role
of
intravitreal
Triamcinolone
(
TA
)
in
the
early
management
of
Coats
disease
.
METHODS
Retrospective
,
interventional
case
series
.
RESULTS
15
consecutive
cases
with
Coats
disease
were
managed
with
4
mg
/
0
.
1
ml
intravitreal
TA
injection
on
presentation
and
were
followed
for
a
minimum
of
1
year
duration
.
Additional
management
strategies
including
drainage
of
subretinal
fluid
through
an
inferior
sclerotomy
,
peripheral
laser
ablation
and
/
or
cryotherapy
,
cataract
extraction
and
vitrectomy
were
performed
.
Improvement
of
visual
acuity
could
be
achieved
compared
with
preoperative
vision
in
all
cases
in
this
series
,
even
when
40
%
needed
cataract
extraction
with
intraocular
lens
implantation
.
One
patient
needed
antiglaucoma
treatment
to
control
raised
intraocular
pressure
in
this
series
.
CONCLUSIONS
Triamcinolone
has
a
role
in
improving
the
rate
of
absorption
of
subretinal
fluid
and
macular
exudates
in
Coats
disease
.
The
major
complication
of
4
mg
/
0
.
1
ml
intravitreal
triamcinolone
is
cataract
in
40
%
of
cases
in
children
.
